Clinical Trials
2 trialsNCT03630809 2022-04-25
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT01042535 2018-04-11
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Completed